AusperBio has raised $37m in a Series A financing round to progress the clinical...
The US Food and Drug Administration (FDA) has granted fast track designation to ...
MSD (Merck & Co) plans to start a Phase IIb/III trial for EyeBio’s lead candidat...
As Wes Streeting takes over the UK’s Department for Health and Social care, inve...
The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital tr...
Ipsen has entered an exclusive global licensing agreement with Foreseen Biotech ...
Bayer and Asklepios BioPharmaceutical (AskBio) have announced FDA fast track des...
Pan Cancer T has announced a €4.25m ($4.62m) seed extension round to complete of...
The cash injection will accelerate the development of Crossject’s prefilled need...
AusperBio Therapeutics and Ausper Biopharma have received breakthrough therapy d...
Research suggests biomanufacturing specialists remain nervy about global supply ...
BioArctic has announced that its partner, Eisai has approval from Hong Kong's De...
Rgenta has secured approval for its IND application for RGT-61159, an oral small...
Preclinical biopharmaceutical company Tiba Biotech has announced a partnership w...
J&J gains Phase II ready NM26, a bispecific antibody in development for the trea...
The deal strengthens Merz’s market position in Parkinson’s disease whilst expand...
